Germany

Southern Europe rues exodus of doctors, nurses as coronavirus surges

Fri, 2020-11-20 11:32 — mike kraft

Southern Europe rues exodus of doctors, nurses as coronavirus surges Thirty-year-old Pep Iglesies emigrated to Canada from Spain in August for a new job that is much like his old one – taking care of coronavirus patients and working as a cardiologist. Joan Faus, Angelo Amante U.S.

BARCELONA/ROME (Reuters) - Thirty-year-old Pep Iglesies emigrated to Canada from Spain in August for a new job that is much like his old one – taking care of coronavirus patients and working as a cardiologist.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Southern Europe rues exodus of doctors, nurses as coronavirus surges
Log in or register to post comments

Roundup: International Deverlopoments on spread of the coronavirus -_Reuters

Thu, 2020-11-19 10:56 — mike kraft

Factbox; Latest on worldwide spread of the coronavirus AstraZeneca and Oxford University's potential COVID-19 vaccine produced a strong immune response in older adults, data published on Thursday showed, with researchers expecting to release late-stage trial results by Christmas. Reuters Staff U.S.

(Reuters) - AstraZeneca and Oxford University’s potential COVID-19 vaccine produced a strong immune response in older adults, data published on Thursday showed, with researchers expecting to release late-stage trial results by Christmas.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Roundup: International Deverlopoments on spread of the coronavirus -_Reuters
Log in or register to post comments

The Vaccines Will Probably Work. Making Them Fast Will Be the Hard Part.

Wed, 2020-11-18 13:48 — mike kraft

The promising news that not just one but two coronavirus vaccines were more than 90 percent effective in early results has buoyed hopes that an end to the pandemic is in sight.

But even if the vaccines are authorized soon by federal regulators — the companies developing them have said they expect to apply soon — only a sliver of the American public will be able to get one by the end of the year. The two companies, Pfizer and Moderna, have estimated they will have 45 million doses, or enough to vaccinate 22.5 million Americans, by January.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about The Vaccines Will Probably Work. Making Them Fast Will Be the Hard Part.
Log in or register to post comments

Pfizer ends vaccine trial with 95% success rate, paving way for a shot this year

Wed, 2020-11-18 08:49 — mike kraft

Pfizer ends vaccine trial with 95% success rate, paving way for a shot this year Final results from Pfizer Inc's COVID-19 vaccine trial showed its shot had a 95% success rate and two months of safety data, paving the way for the drugmaker to apply for an emergency U.S. authorization within days, it said on Wednesday. Michael Erman U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pfizer ends vaccine trial with 95% success rate, paving way for a shot this year
Log in or register to post comments

Pfizer to start pilot delivery program for its COVID-19 vaccine in four U.S. states

Tue, 2020-11-17 11:16 — mike kraft

Pfizer to start pilot delivery program for its COVID-19 vaccine in four U.S. states Pfizer Inc <PFE.N> has launched a pilot delivery program for its experimental COVID-19 vaccine in four U.S. states, as the U.S. drugmaker seeks to address distribution challenges facing its ultra-cold storage requirements. Reuters Staff U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pfizer to start pilot delivery program for its COVID-19 vaccine in four U.S. states
Log in or register to post comments

Pfizer vs Moderna vaccines: What we know, and what we don't

Mon, 2020-11-16 19:21 — mike kraft

Pfizer vs Moderna vaccines: What we know, and what we don't Two vaccine candidates using similar technology are winning the COVID-19 vaccine race in the U.S., and in the process validating the mRNA platform — which is yet untested on the market— as well as setting the path for vaccine makers to follow in order to block the virus. YahooNews

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Pfizer vs Moderna vaccines: What we know, and what we don't
Log in or register to post comments

Bars and shops closed as Europe battles second wave of coronavirus

Mon, 2020-11-16 12:19 — mike kraft

Bars and shops closed as Europe battles second wave of coronavirus Strict measures – including curfews and states of emergencies – are in force once more across the continent as Covid cases surge Emma Graham-Harrison the Guardian

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Bars and shops closed as Europe battles second wave of coronavirus
Log in or register to post comments

Moderna, 2nd virus vaccine shows overwhelming success in U.S. tests

Mon, 2020-11-16 10:26 — mike kraft

2nd virus vaccine shows overwhelming success in U.S. tests Moderna said Monday its COVID-19 vaccine is proving to be highly effective in a major trial, a second dash of hope in the global race for a shot to tame a resurgent virus that is now killing more... AP NEWS

Moderna said Monday its COVID-19 vaccine is proving to be highly effective in a major trial, a second dash of hope in the global race for a shot to tame a resurgent virus that is now killing more than 8,000 people a day worldwide.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Moderna, 2nd virus vaccine shows overwhelming success in U.S. tests
Log in or register to post comments

International roundup of COVID-19 developments -Reuters

Sat, 2020-11-14 11:24 — mike kraft

Latest on worldwide spread of the coronavirus Delhi's COVID-19 deaths rose by a record number on Thursday and it reported the most infections in India, as government officials in Germany dampened hopes that a partial lockdown there would be lifted at the end of November. Reuters Staff U.S.

Reuters) - Delhi’s COVID-19 deaths rose by a record number on Thursday and it reported the most infections in India, as government officials in Germany dampened hopes that a partial lockdown there would be lifted at the end of November.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about International roundup of COVID-19 developments -Reuters
Log in or register to post comments

What's next for COVID-19 apps? Governance and oversight

Fri, 2020-11-13 19:41 — mike kraft

Science Article

Studies conducted in April and May 2020 showed that in countries like the United States, Switzerland, and Italy, between 55 and 70% of adults in all age groups were willing to download a contact tracing app (5).

Yet these figures do not match the current DCT apps uptake. Even in countries with robust privacy safeguards in place, downloads of DCT apps have been below expectations. At the time of writing, the Australian DCT app has been downloaded by 6.5 million (26% of the population), the Italian one by 8 million (13.4%), and the newly released French one by 1.5 million (2.3%). Ireland has about 1.3 million active app users (24%), Switzerland 1.8 million (21.5%), and Germany 16 million (19.3%).

Country / Region Tags:

General Topic Tags: